A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours
ATTARD, G, KITZEN, J, BLAGDEN, S. P, FONG, P. C, PRONK, L. C, ZHI, J, ZUGMAIER, G, VERWEIJ, J, DE BONO, J. S, DE JONGE, M
Published in British journal of cancer (19.11.2007)
Published in British journal of cancer (19.11.2007)
Get full text
Journal Article
The phospholipid composition and cholesterol content of platelet‐derived microparticles: a comparison with platelet membrane fractions
BIRÓ, É., AKKERMAN, J. W. N., HOEK, F. J., GORTER, G., PRONK, L. M., STURK, A., NIEUWLAND, R.
Published in Journal of thrombosis and haemostasis (01.12.2005)
Published in Journal of thrombosis and haemostasis (01.12.2005)
Get full text
Journal Article
Phase II study comparing pembrolizumab (PEM) with intermittent/short‐term dual MAPK pathway inhibition plus PEM in patients harboring the BRAFV600 mutation (IMPemBra)
Rozeman, E.A., Sikorska, K., Grijpink-Ongering, L., Heeres, B.C., van de Wiel, B.A., Sari, A., Mallo, H., Adriaansz, S., Uyterlinde, W., Lijnsvelt, J., Pronk, L.M., Haanen, J.B.A.G., de Groot, J.W.B., Wilgenhof, S., Vollenbergh, M.A., van Thienen, J.V., Blank, C.U.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Downsizing of locally advanced stage III (bulky) BRAF V600E/K melanoma with combination targeted therapy to achieve R0 resection
Haanen, J, Blank, C, Van Thienen, H, Mallo, H, Adriaansz, S, Ter Meulen, S, Madu, M, Pronk, L, Van der Hiel, B, Van de Wiel, B, Peeper, D, Van Akkooi, A
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
Randomized phase III study comparing a non-myeloablative lymphocyte depleting regimen of chemotherapy followed by infusion of tumor infiltrating lymphocytes and interleukine-2 to standard ipilimumab treatment in metastatic melanoma
Rohaan, M.W., Borch, T.H., van den Berg, J.H., Geukes Foppen, M.H., Donia, M., Met, Ö, Nuijen, B., van Zon, M., Bakker, E.A.M., de Boer, R., Pronk, L.M., Wilgenhof, S., Blank, C.U., van Thienen, J.V., van Akkooi, A.C.J., Svane, I.-M., Haanen, J.B.A.G.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A phase lb study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours
Attard, G, Kitzen, J, Blagden, S P, Fong, P C, Pronk, L C, Zhi, J, Zugmaier, G, Verweij, J, de Bono, JS, de Jonge, M
Published in British journal of cancer (19.11.2007)
Published in British journal of cancer (19.11.2007)
Get full text
Journal Article
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
PRONK, L. C, VASEY, P, SPARREBOOM, A, REIGNER, B, PLANTING, A. S. T, GORDON, R. J, OSTERWALDER, B, VERWEIJ, J, TWELVES, C
Published in British Journal of Cancer (01.07.2000)
Published in British Journal of Cancer (01.07.2000)
Get full text
Journal Article
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors
Pronk, L C, Schellens, J H, Planting, A S, van den Bent, M J, Hilkens, P H, van der Burg, M E, de Boer-Dennert, M, Ma, J, Blanc, C, Harteveld, M, Bruno, R, Stoter, G, Verweij, J
Published in Journal of clinical oncology (01.03.1997)
Published in Journal of clinical oncology (01.03.1997)
Get more information
Journal Article
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin
HILKENS, P. H. E, PRONK, L. C, VERWEIJ, J, VECHT, C. J, VAN PUTTEN, W. L. J, VAN DEN BENT, M. J
Published in British journal of cancer (01.01.1997)
Published in British journal of cancer (01.01.1997)
Get full text
Journal Article
Phase I/II trial of irinotecan plus high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy in advanced colorectal cancer
Aranda, E., Carrato, A., Cervantes, A., Sastre, J., Gómez, M. A., Abad, A., Masutti, B., Ribera, F., Marcuello, E., Pronk, L., Balcells, M., Díaz-Rubio, E.
Published in Annals of oncology (01.04.2004)
Published in Annals of oncology (01.04.2004)
Get full text
Journal Article
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours
PRONK, L. C, SCHRIJVERS, D, SCHELLENS, J. H. M, DE BRUIJN, E. A, PLANTING, A. S. T, LOCCI-TONELLI, D, GROULT, V, VERWEIJ, J, VAN OOSTEROM, A. T
Published in British journal of cancer (01.01.1998)
Published in British journal of cancer (01.01.1998)
Get full text
Journal Article
Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial
STOUTHARD, J. M. L, GOEY, H, DE VRIES, E. G. E, DE MULDER, P. H, GROENEWEGEN, A, PRONK, L, STOTER, G, SAUERWEIN, H. P, BAKKER, P. J. M, VEENHOF, C. H. N
Published in British journal of cancer (01.03.1996)
Published in British journal of cancer (01.03.1996)
Get full text
Journal Article
JS07.4.A A PHASE 0/IA STUDY OF BRIGIMADLIN CONCENTRATION IN BRAIN TISSUE AND A DOSE ESCALATION STUDY OF BRIGIMADLIN PLUS RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Sarkaria, J N, Mrugala, M M, Jaeckle, K A, Burns, T C, Vaubel, R A, Parney, I F, Chaichana, K L, Clement, P M, Martínez-García, M, Sepúlveda Sanchez, J M, Omuro, A, Pronk, L, Ross, H, Teufel, M, Hesse, R, Grempler, R, Galanis, E
Published in Neuro-oncology (Charlottesville, Va.) (17.10.2024)
Published in Neuro-oncology (Charlottesville, Va.) (17.10.2024)
Get full text
Journal Article
The venotonic drug hydroxyethylrutosiden does not prevent or reduce docetaxel-induced fluid retention: results of a comparative study
PRONK, L. C, VAN PUTTEN, W. L. J, VAN BEURDEN, V, DE BOER-DENNERT, M, STOTER, G, VERWEIJ, J
Published in Cancer chemotherapy and pharmacology (1999)
Published in Cancer chemotherapy and pharmacology (1999)
Get full text
Journal Article
Phase 2 Study Comparing Pembrolizumab with Intermittent/short-term dual MAPK pathway inhibition plus Pembrolizumab(PEM) in patients harboring the BRAFV600 mutation (IMPemBra Trial)
Rozeman, E.A., Deken, M.A., Gadiot, J., Geukes Foppen, M.H., Pronk, L., Thienen, J.V., Haanen, J.B., Blank, C.U.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Phase 2 Study Comparing Pembrolizumab with Intermittent/short-term dual MAPK pathway inhibition plus Pembrolizumab(PEM) in patients harboring the BRAFV600 mutation (IMPemBra Trial)
Rozeman, E.A., Deken, M.A., Gadiot, J., Geukes Foppen, M.H., Pronk, L., Thienen, J.V., Haanen, J.B., Blank, C.U.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Pharmacokinetics of ifosfamide are changed by combination with docetaxel: results of a phase I pharmacologic study
Schrijvers, D, Pronk, L, Highley, M, Bruno, R, Locci-Tonelli, D, De Bruijn, E, Van Oosterom, A T, Verweij, J
Published in American journal of clinical oncology (01.08.2000)
Published in American journal of clinical oncology (01.08.2000)
Get more information
Journal Article